FZD6 and prostate carcinoma: To investigate the mechanisms by which FZD6 knockdown impairs the growth and DNA damage repair of prostate cancer cells, we performed a reverse-phase protein array (RPPA) with 466 antibodies to identify differentially expressed proteins between the DU145 cells expressing the FZD6 shRNAs and control scrambled shRNA.